Jianmin Pharmaceutical Group Co Ltd
600976
Company Profile
Business description
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
Contact
No. 484 Parrot Avenue
Hanyang District
Wuhan430052
CHNT: +86 2784523350
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
2,257
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
Microsoft’s earnings report is expected to touch on AI adoption and monetization.
stocks
World’s largest miner overvalued after solid quarter
The ongoing war is likely to keep commodity prices even more volatile than usual until it is resolved.
stocks
Hidden value in an expensive ASX
How investors can uncover value beyond the index heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,024.90 | 26.50 | -0.29% |
| CAC 40 | 8,156.43 | 79.28 | -0.96% |
| DAX 40 | 24,194.90 | 75.97 | -0.31% |
| Dow JONES (US) | 49,490.03 | 340.65 | 0.69% |
| FTSE 100 | 10,476.46 | 21.63 | -0.21% |
| HKSE | 26,024.72 | 138.52 | -0.53% |
| NASDAQ | 24,657.57 | 397.60 | 1.64% |
| Nikkei 225 | 59,434.94 | 150.92 | -0.25% |
| NZX 50 Index | 12,873.77 | 71.83 | -0.55% |
| S&P 500 | 7,137.90 | 73.89 | 1.05% |
| S&P/ASX 200 | 8,788.20 | 31.30 | -0.35% |
| SSE Composite Index | 4,110.48 | 4.23 | 0.10% |